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Abstract PA28, a 200 kDa activator of 20S proteasomes, was 
purified from human placenta and was gel electrophoretically 
resolved into two different subunits, a and [~. In reconstitution 
experiments, ¢z-subunits alone were found to re-associate forming 
homooligomers with an Mr of about 200 kDa, which elicit a 
stimulatory effect on proteasomal peptide-hydrolyzing activity, 
albeit at a moderate level. Under the same conditions, isolated ~- 
subunits were neither found to associate nor did they display 
stimulatory activity. Significantly, when both a- and I~-subunits 
were present in the reconstitution assay, heteromuitimers formed, 
concomitant with a marked increase in stimulatory activity when 
compared with that of c¢-homooligomers. The reconstituted 
PA28¢x,[~ protein is indistinguishable from purified PA28 by 
several criteria: it displays the same molecular mass, shows the 
same abundance of ¢x- and ~subunits and has a similar 
stimulatory activity toward 20S proteasomes. These results 
indicate that optimal PA28 activity is associated with a 
heteromultimeric structure which contains the c¢- and [~-subunits 
in fixed stoichiometry, most likely as an a3[~3-heterohexamer. 
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I. Introduction 
toward small synthetic peptides but not toward larger protein 
substrates [4,5,8]. Very recently, a cellular function for PA28 
in antigen processing has been proposed by demonstrating 
that overexpression of PA28e~ in mouse fibroblasts results in 
an improved antigen presentation [9]. This correlates with in 
vitro experiments on 20S proteasome digests of viral peptides, 
where PA28 promotes a shift in cleavage mechanism that 
leads to a largely enhanced production of immunodominant 
peptide or potential precursors [10]. While these studies have 
established a cellular role for PA28, the underlying mechan- 
ism of action has remained ifficult to interpret, owing in part 
to a lack of knowledge about the composition and stoichiom- 
etry of the activator protein. For example, in a study report- 
ing the properties of recombinant PAc~ [1 I] this activator was 
found to be functionally very similar if not identical to PA28 
directly isolated from human tissue and containing both c~- 
and [3-subunits. Thus, if PA28c~ is sufficient to elicit a full 
stimulatory effect, what is the role of the J3-subunit, if any? 
To address these questions, we have isolated the c~- and [3- 
subunits from purified PA28 and have performed reconstitu- 
tion experiments which show that optimal activity is asso- 
ciated with an cd[3-heteromultimer of fixed stoichiometry, 
most likely an c~a[33-heterohexamer. 
Proteasomes are non-lysosomal proteolytic complexes of 
high molecular mass (,~ 700 kDa), composed of multiple sub- 
units, which are arranged in four stacks of seven-membered 
rings. These subunits can be grouped into two families, related 
either to the c~- or to the ]3-subunit of proteasomes from the 
archaebacterium Thermoplasma acidophilum (for a review, see 
[1]). In mammalian cells, proteasome activity is modulated by 
specific regulatory proteins which form proteasome-regulator 
complexes. One of these, designated 19S regulator or PA700 
[2], is a large, multisubunit complex. With the 20S proteasome 
as a core enzyme and 19S regulator complex associated at 
either terminal ring of the proteinase, the 26S proteasome is
formed which is essential for ATP-ubiquitin-dependent pro- 
tein degradation [3]. Another regulator, termed PA28 [4] or 
l lS  regulator [5], is a 200 kDa protein and is composed of 
two different ypes of polypeptide, designated c~ and f3 [6]. The 
subunits are arranged in a ring-like structure and 'cap' one or 
both of the 20S proteasome's terminal rings [7]. Until now, 
the in vivo function of PA28 has remained uncertain, since the 
activator had been found to stimulate proteasomal activity 
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2. Materials and methods 
DEAE-cellulose (DEAE-Servacel) and DTT were bought from Ser- 
va, Heidelberg (Germany). Gel filtration standard proteins, DEAE- 
Sephacel, Sepharose CL-6B as well as Mono-Q HR 5/5, Superose 6 
HR 10/30 and Phenyl Superose HR 5/5 pre-packed columns were 
obtained from Pharmacia Biotech GmbH, Freiburg (Germany). Pre- 
packed columns were run in conjunction with the Pharmacia FPLC 
system. The fluorogenic peptide, Suc-LLVY-MCA was from Bachem 
Biochemica GmbH, Heidelberg (Germany). Alkaline phosphatase- 
conjugated anti-rabbit IgG came from Sigma Chemie GmbH, Deisen- 
hofen (Germany). SDS/PAGE molecular weight standards and hy- 
droxyapatite (DNA grade) were from Bio-Rad GmbH (Munich, Ger- 
many). Polyvinylidenedifluoride (PVDF) blotting membrane was from 
Millipore (Eschborn, Germany). All other chemicals were of analyti- 
cal grade. 
2.1. Purification of PA28 
PA28 was prepared from human placenta by tissue homogenization 
in a solution of phosphate-buffered, isotonic sucrose, fractional cen- 
trifugation at 15000xg for 30 min and 100000×g for 60 min, and by 
subjecting the resulting supernatant to the purification scheme de- 
scribed for PA28 from rabbit skeletal muscle [8]. 
2.2. Purification of 20S proteasome 
The proteinase was purified from outdated human blood as detailed 
in [12]. 
Abbreviations." BSA, bovine serum albumin; DTT, dithioerythritol; 
EDTA, ethylenediaminetetraacetic id; MCA, 7-amino-4-methylcou- 
marin; PAGE, polyacrylamide g l electrophoresis; PVDF, polyvinyl- 
idenedifluoride; SDS, sodium dodecyl sulfate; Suc, succinyl 
2.3. Assay of 20S proteasomes and PA28 activator 
The activator assays contained 1 tag of proteasome protein in 
TEAD buffer (20 mM Tris-HCl/1 mM EDTA/1 M NaNJ1 mM 
DTT, pH 7.5) without or with activator fractions and TEAD buffer 
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to 100 gl. Samples were pre-incubated for 10 rain at 37°C prior to 
addition of Suc-LLVY-MCA (100 ~tM final concentration) to a final 
volume of 200 ~tl. After incubation for 15 min at 37°C, the reaction 
was terminated and the reporter group was monitored spectrofluo- 
rometrically as in [8]. 
2.4. Electrophoretic techniques 
Electrophoresis under denaturing conditions in SDS-containing, 
10 20% (w/v) polyacrylamide linear gradient gels was as described 
previously [8] or using the discontinuous tricine-SDS-PAGE system 
[13]. Gels were stained with Coomassie brilliant blue. Semi-dry Wes- 
tern blotting of proteins following PAGE and detection of antigen- 
antibody complex were carried as in [8]. 
2,5. Antibodies 
Polyclonal antibody to proteasome activator isolated from human 
placenta was raised in rabbits and isolation of the IgG fraction from 
whole antiserum was as in [8]. 
2.6. Isolation of PA28 ¢x- and ~-subunits 
Separation of the two subunits was as in [8], with the following 
changes: after the electrophoretic run, excision of the bands contain- 
ing the separated subunits and electroelution, samples were concen- 
trated to about 1 ml in a Centricon 3 microconcentrator, P otein was 
precipitated with a 10-fold volume of ice-cold acetone. After overnight 
standing at -20°C, samples were centrifuged and the supernatants 
were discarded. Precipitates were dissolved in a small volume of 
TEAD buffer and insoluble material was spun down (40000 ×g, 15 
rain). The resulting supernatants were used for reconstitution experi- 
ments as described below. 
2.7. Reconstitution of PA28 Jrom isolated subunits 
Single subunits or both at a protein ratio of 1 : 1 were mixed with an 
equal volume of glycerol for storage at -20°C. Prior to measuring 
stimulatory activity toward 20S proteasomes, amples were dialyzed 
against TEAD buffer. 
2.8. Other methods 
Protein concentrations were determined by the method of Bradford 
[22], with Lab-Trol (Dade, Miami, FL, USA) as the standard. 
All other experimental details were as given in the table and figure 
legends. 
3. Results 
PA28 c~- and [~-subunits differ only little in their Mr and 
they migrate very closely upon SDS-PAGE ([8], Fig. 1). As 
the interpretation of reconstitution experiments critically de- 
pends on a quantitat ive separation of the two subunits, their 
homogeneity was assessed by Western blotting, using an anti- 
PA28~,~ ant ibody as a probe. As il lustrated in Fig. 2, with 
purified PA28, both subunits are recognized by the antibody, 
whereas with isolated subunits, the reaction is confined to a 
single band, with no addit ional protein reacting, indicating 
Table 1 
Effect of native PA28 and of isolated subunits on 20S proteasomal 
activity 
Addition of Activation of LLVY hydrolysis (fold) 
Control 1 _+0.1 
PA28 native 16 _+ 1.3 
c~-subunit 3.5 + 0.2 
~-subunit 1 + 0.2 
c~- plus [3-subunit 13 + 2.1 
1 pg each of the indicated fractions (a- plus !3-subunits as a 1:1 
mixture) was added to 1 pg of purified proteasome protein. Incuba- 
tion conditions and determination f LEVY hydrolyzing activity were 
as detailed in Section 2. The control consisted of 1 ~g of BSA which 
had been subjected to the same steps as those applied for the isolation 
of PA28 subunits. Values given are means + S.E.M. from three inde- 
pendent experiments. 
L. Kuehn, B. Dahlmann/FEBS Letters 394 (1996) 183-1 
a b 
31k-  - -  
Fig. 1. SDS-PAGE of proteasome activator subunits. 1 lag of acti~ 
tor subunit protein, isolated as detailed in Section 2, was elect1 
phorized on a SDS-polyacrylamide g l with a 10 20% (w/v) contin 
ous acrylamide gradient. Electrophoresis, taining with Coomas: 
blue and destaining were as detailed elsewhere [8]. a and b, isolat 
c~- and ~-subunit, respectively. 
that the respective band corresponds to a homogeneous po 
ulation of either the a- or the [~-subunit. 
We then examined the ability of isolated PA28 subunits 
stimulate peptide-hydrolyzing activity by 20S proteasom~ 
The results of these experiments can be summarized as follm 
(Table 1). In the presence of purified PA28, proteasom 
LLVY-hydrolyzing activity is stimulated 16-fold. The c~-su 
unit protein alone elicits a stimulatory effect (3.5-fold) whi, 
is, however, low when compared to that of native PA28. Wi 
the single [~-subunit protein, no stimulatory activity is dete( 
able. In the presence of both subunits at a 1 : 1 ratio, stimul 
t ion of proteasomal activity is markedly enhanced, attaining 
value similar to that elicited by native PA28. As PA28 su 
units had been separated on SDS-containing els and wi 
SDS activating 20S proteasomes [14], it might be argu~ 
that residual detergent present in the samples mimics the a 
tion of PA28 subunits. This, however, appears highly unlike 
as the ~-subunit shows no stimulatory activity. Furthermol  
BSA, which is not a substrate for 20S proteasomes [12], su 
jected to the same protocol as that for isolation of the a- al 
[~-subunits, was found to be without effect on proteasom 
activity. These results rather suggest hat the stimulatory 
fect measured in the presence of c~-subunit protein alone or ,  
subunit protein together with an equal amount  of [3-subur 
protein reflects an inherent property of PA28 subunits. 
In keeping with earlier findings that, both for purified PAl 
[4,5,8] and for recombinant PA28o~ [11], stimulatory activity 
associated with an oligomeric structure, gel fi ltration expe~ 
ments (Fig. 3) illustrate that proteasomal activation by the,  
subunit, as well as by a mixture of equal amounts of c~- and 
protein, is associated with multimers of Mr about 200 k£ 
which yield, upon SDS-PAGE (Fig. 3, insets), the constitue 
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Fig. 2. Western blot analysis of purified PA28 activator and of iso- 
lated activator subunits. 2 p.g of purified activator protein and 1 gg 
of isolated subunit were electrophoresed on a discontinuous tricine 
SDS-polyacrylamide g l prepared according to [13], with a 16.5% T 
and 3% C separating el. Following electrophoresis, the gel was 
semi-dry blotted onto PVDF membranes and probed with rabbit 
anti-human activator antibody. Primary antibody was visualized 
with alkaline phosphatase-conjugated goat anti-rabbit IgG as de- 
scribed elsewhere [12]. Lane 1, purified PA28; lanes 2 and 3, iso- 
lated c~- and ]3-subunit, respectively. 
subunit(s). Significantly, this all3 multimer, which has been 
reconstituted from the isolated subunits, is resolved into the 
same two bands of 31 and 29 kDa as found for purified PA28 
with this type of analysis [8,15] and, as judged by the intensity 
of Coomassie staining, the subunits occur at equal abundance, 
a strong indication that optimal PA28 activity is associated 
with a heteromultimeric complex containing the a- and 13- 
subunits in a fixed stoichiometry, most likely as an cca133-het- 
erohexamer. In contrast, upon gel filtration of isolated 13-sub- 
units, no stimulatory activity was detectable in the eluate frac- 
tions nor was any protein measurable in fractions 26-33, 
those fractions where active ~- or a/13-oligomers are eluted 
from the column (data not shown). 
In conclusion, these experiments have demonstrated that 
isolated PA28 subunits can re-associate to form two distinct 
oligomers, a homomultimer exclusively composed of ~-subu- 
nits displaying moderate stimulatory activity as well as an cd 
13-heteromultimer, having an activity similar to that found for 
native PA28, purified from placenta. 
4. D iscuss ion  
In agreement with earlier reports on PA28 from a number 
of different species and tissues [6,11,15], human placenta pro- 
vides a further example of activator protein to be composed 
of two different types of polypeptide. The experiments de- 
scribed here extend those findings to the identification of 
PA28 cd[3-heteromultimers a the structural organization 
that optimally stimulates peptide hydrolysis by 20S protea- 
somes. This is achieved by adding to a polypeptide with the 
ability to self-associate and displaying moderate stimulatory 
activity a polypeptide with neither of these properties. This 
situation is reminiscent of the assembly process of the 20S 
proteasome, where c~-type subunits are thought to first assem- 
ble, forming a ring-like structural backbone on which the [3- 
type subunits assemble to give the fully assembled, functional 
c~7137137c~7 proteasome [16,17,23]. PA28 is known to elicit its 
stimulatory activity by associating with the terminal rings of 
20S proteasomes [7]. Two of the proteasomal a-subunits, 
XAPC7 and C9, and constituents of the terminal ring as 
well as the PA28 c~-subunit [18], but not the 13-subunit [6] 
contain KEKE motifs which have been implicated in the in- 
teraction between the two protein complexes [18]. The results 
of our reconstitution experiments support the importance of 
such motifs for the interaction of PA28 with proteasomes, as 
the activator [3-subunits alone are not able to form active 
complexes with proteinase but only KEKE-containing c~-sub- 
units or ~13-heteromultimers. However, c~-subunits alone lead 
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Fig. 3. Molecular sizing chromatography of isolated PA28 subunit (x- and of the o~- plus [3-subunit. A 500 gl sample containing 100 gg of 
PA28 c~-subunit (left panel), and a sample consisting of equal amounts of c~- and [3-subunit (right panel) were subjected to gel filtration on a 
Superose 6 HR 10/30 column. TEAD was used as the sample and running buffer. The flow rate was 0.5 ml/min and fractions of 0.5 ml were 
collected. 25 gl aliquots were assayed for activator as described in Section 2. Insets: Aliquots of the pooled fractions 28 32 were concentrated 
in Centricon 10 concentrators and analyzed by SDS-PAGE as given in the legend to Fig. 1. The calibration run was performed with protein 
standards of known molecular mass: Vo, blue dextran (Mr 2200000); I, thyroglobulin (Mr 669000); II, ferritin (Mr 440000); Ill, catalase (Mr 
232000); IV, aldolase (Mr 158000). 
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only to partial activation (Table 1, Fig. 3), indicating that 
contact sites between proteasomes and [5-subunits mediated 
in conjunction with ~-subunits may also be of importance. 
This is supported by the finding that the interaction between 
PA28 and proteasomes is inhibited not with antibodies against 
proteasome subunits XAPC7 or C9 [19] but with an antibody 
against subunit C3 [19] or C2 [20], neither of which contains 
KEKE motifs [21]. 
To explain the existence of a two-subunit activator protein, 
it has been hypothesized that the two PA28 subunits may 
have become specialized with regard to function [15]. Our 
data, together with those reported for the in vitro activity of 
recombinant PA28~ [11] as well as studies in vivo with cells 
over-expressing PA28c~ [9], would be compatible with such a 
model. Moreover, our results open the possibility that individ- 
ual PA28 subunits might associate with other cellular proteins 
such as Ki antigen [6], either to co-ordinately modulate a 
proteasome-catalyzed degradative process such as antigen 
processing or to mediate other cellular functions which remain 
to be identified. The experiments reported here provide a basis 
for the search for such proteins. 
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